Our studies indicate that in lung adenocarcinoma cells, a relatively slow rate of transcriptional activation of the p27Kip1 gene that occurs at relatively high GR levels accounts for the progressive accumulation of p27Kip1 in response to Dex treatment. The gene discussed is CDKN1B; the disease is lung adenocarcinoma.